Therapeutic genome editing in cardiovascular diseases

DM German, S Mitalipov, A Mishra, S Kaul - JACC: Basic to Translational …, 2019 - jacc.org
A variety of genetic cardiovascular diseases may one day be curable using gene editing
technology. Germline genome editing and correction promises to permanently remove …

Therapeutic genome editing in cardiovascular diseases

M Nishiga, LS Qi, JC Wu - Advanced drug delivery reviews, 2021 - Elsevier
During the past decade, developments in genome editing technology have fundamentally
transformed biomedical research. In particular, the CRISPR/Cas9 system has been …

Genome editing in cardiovascular diseases

A Strong, K Musunuru - Nature Reviews Cardiology, 2017 - nature.com
Genome-editing tools, which include zinc finger nucleases (ZFNs), transcription activator-
like effector nucleases (TALENs), and clustered regularly interspaced short palindromic …

Genome editing for the study of cardiovascular diseases

AC Chadwick, K Musunuru - Current cardiology reports, 2017 - Springer
Abstract Purpose of Review The opportunities afforded through the recent advent of genome-
editing technologies have allowed investigators to more easily study a number of diseases …

The impact of CRISPR/Cas9 technology on cardiac research: from disease modelling to therapeutic approaches

BM Motta, PP Pramstaller, AA Hicks… - Stem cells …, 2017 - Wiley Online Library
Genome‐editing technology has emerged as a powerful method that enables the generation
of genetically modified cells and organisms necessary to elucidate gene function and …

Genome editing technology: A new frontier for the treatment and prevention of cardiovascular diseases

S Saeed, SU Khan, WU Khan… - Current Problems in …, 2023 - Elsevier
Over the past 2 decades, genome-editing technique has proven to be a robust editing
method that revolutionizes the field of biomedicine. At the genetic level, it can be efficiently …

CRISPR modeling and correction of cardiovascular disease

N Liu, EN Olson - Circulation research, 2022 - Am Heart Assoc
Cardiovascular disease remains the leading cause of morbidity and mortality in the
developed world. In recent decades, extraordinary effort has been devoted to defining the …

Recent advances in CRISPR-based genome editing technology and its applications in cardiovascular research

ZH Li, J Wang, JP Xu, J Wang, X Yang - Military Medical Research, 2023 - Springer
The rapid development of genome editing technology has brought major breakthroughs in
the fields of life science and medicine. In recent years, the clustered regularly interspaced …

CRISPR/Cas9 gene-editing strategies in cardiovascular cells

E Vermersch, C Jouve, JS Hulot - Cardiovascular research, 2020 - academic.oup.com
Cardiovascular diseases are among the main causes of morbidity and mortality in Western
countries and considered as a leading public health issue. Therefore, there is a strong need …

CRISPR-Cas9 genome editing for treatment of atherogenic dyslipidemia

AC Chadwick, K Musunuru - Arteriosclerosis, thrombosis, and …, 2018 - Am Heart Assoc
Although human genetics has resulted in the identification of novel lipid-related genes that
can be targeted for the prevention of atherosclerotic vascular disease, medications targeting …